Migraines – Ages 6 to 17
PMG Research of Winston Salem
A research study is evaluating an investigational, fast-acting medication (FDA-approved for adults) for the acute treatment of migraines for children ages 6 to 17.
This research study may be an option if your child:
· Has been experiencing 2 – 8 moderate-to-severe migraines per month in the past 2 months
· Can swallow a tablet
· Has a body weight of at least 33 pounds
Other criteria apply.
Qualified participants will receive all study-related care and study medication at no cost.
Participants who complete this study may have the option to join an open-label extension study, which means all participants will receive study medication for the duration of the extension.
Patient Commitment Duration
Approximately 5 months
Financial compensation will be provided for time and travel expenses.
Number of visits in study
Approximately 4 clinic visits